Join us at the Biocides Europe 2021 Virtual Conference on 1-2 December 2021. A variety of topics will be discussed: regulatory processes in the European biocides sector, labelling issues for biocides, improving implementation of the Biocidal Products Regulation (EU) 528/2012 (BPR), and more.
Anna and Lorna will be available throughout this conference to meet with you and answer any questions you have regarding our regulatory and technical consultancy services.
CSI has an established reputation in supporting registration of a range of biocidal products including disinfectants, sterilizers, preservatives, and unique antimicrobial applications. We support clients introducing their products in European and North American markets through cost-effective strategies.
In Europe, we assist with active substance approval and biocidal product authorisations to comply with the requirements for the European Economic Area (EEA) (i.e. EU27 plus Iceland, Liechtenstein and Norway). With the new GB BRP regulation now in force for Great Britain, CSI is able to offer GB Article 95 representative support for EU companies.
In the US, we help clients with US Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) regulated antimicrobial products, as well as State registration management.
We also support the global marketplace and have successfully assisted firms with registrations in Canada, Latin America, Asia (China/Taiwan), Australasia, and other geographical markets.
Experienced Support For:
- Registration Dossier Preparation & Submission
- Regulatory Strategy
- Data Review & Evaluation
- Hazard, Exposure, & Risk Assessments for Human Health & Environment
- Task Force Management
- Litigation Support